AIMS 2025: Emmanuel J Favaloro’s Haemostasis Tour Hits Finale
Emmanuel J Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, posted on LinkedIn:
”Just completed my final session as the Australian Institute of Medical and Clinical Scientists (AIMS) 2025 Travelling Orator, in Adelaide for the South Australian (SA)/Northern Territory (NT) Branch. A well organised and well attended (pre-)Christmas meeting where I spoke on the topic of “Advances in Haemostasis”. This assignment has been an honour for me.
In total, 6 different venues, with 11 presentations, covering all states and territories in Australia (bar Queensland and the ACT). In total, around 500 attendees, both young and not so young.
Hope to be selected again before I hang up my haemostasis hat for good.”
Stay updated with Hemostasis Today.
-
Nov 3, 2026, 02:21Digambar Panchal: NGS Demonstrates Key Role in Solving Challenging Hematology Cases at LTMGH
-
Nov 3, 2026, 02:07David Smadja: Does Immediate Breast Reconstruction Increase the Risk of Thrombosis and Bleeding after a Mastectomy?
-
Nov 3, 2026, 01:57Nour Al-Mozain: What Does a Bathtub Have to Do with Hemoglobin S?
-
Nov 3, 2026, 01:51Cesar de Almeida Neto: Highlighting The Final Day of Hemo 2026
-
Nov 3, 2026, 01:34Jae Hyun Byun: Beyond Stenosis Understanding Carotid Plaque Instability
-
Nov 3, 2026, 01:20Smriti Yadav: A New Milestone in Transfusion Medicine
-
Nov 3, 2026, 00:55Dušan Ušjak: A Month of Research and Scientific Collaboration
-
Nov 3, 2026, 00:27Grace Gorecki: Early IVIG Accelerates Platelet Recovery in HIT
-
Nov 2, 2026, 22:15Micheline Mambue: A Case of Early Stent Thrombosis Successfully Managed With Repeat Angioplasty